Our CEO-CSO and COO attended the last edition of Biofit in Lille on December 3rd-4th co-organized this year with MedFIT.

DRUGABILIS presence on the AFSSI booth enabled numerous interactions with TTO/SATT reps, biotech team-leaders and complementary preclinical R&D service providers, sharing with them details about our pharmaceutical drugability service offer for early R&D during very valuable B2B meetings.

DRUGABILIS also participated to on-line meetings, which facilitated networking with unavailable partners in Lille.

Several of these fruitful exchanges are expected to lead to new collaborations in the coming year…

We want to thank the organizers and the attendees… and we’ll be glad to attend Biofit edition next year!

2024 edition key figures >

Back to All drugability services >

Any specific issue you want to discuss?